Notal Vision Monitoring Center Reports AI Analysis of 10
Milestone demonstrates strong patient and physician engagement by digital healthcare provider...
Stay updated with breaking news from Visual Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Milestone demonstrates strong patient and physician engagement by digital healthcare provider...
The first topical preparation to treat presbyopia -- farsightedness caused by loss of elasticity of the lens of the eye, typically occurring in middle and old age -- has won approval from the FDA.
Wet AMD gets Susvimo, an intravitreal ranibizumab injection, and macular edema gets Xipere, a triamcinolone acetonide injectable suspension.
In real-world studies, switching to brolucizumab led to improvements in signs of wet macular degeneration.
PressNetwork – Presseportal für Pressemitteilungen und Unternehmens-News